Krsnaa Diagnostics Limited (KRSNAA) fundamentals
Krsnaa Diagnostics Limited is a listed company in Healthcare Services, part of the Healthcare sector, listed on the NSE as KRSNAA (ISIN INE08LI01020). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Krsnaa Diagnostics Limited does
Krsnaa Diagnostics Limited is engaged in the business of providing diagnostic services primarily in relation to pathology investigation, radiology investigation, and tele reporting. The Company’s services include pathology, X-Ray and computed tomography (CT) scans, magnetic resonance imaging (MRI), ultrasonography (USG), tele-radiology, tele-pathology, and other diagnostic services. Its laboratory services span a diverse range of investigations, ranging from CBC or blood glucose to highly specialized tests. Its tele-radiology services enable radiologists to offer treatment remotely. Tele-radiology involves transmitting radiological images, such as CT scans, digitized X-rays, MRIs, and ultrasounds between different locations. It offers Ayaksham package, which includes from basic to total plus health checkups. It provides diagnostic testing packages for diabetes, heart health, liver health, kidney health, thyroid, fatigue, cancer, senior citizen care, bone health, and others.
Valuation and market data
| Last close | ₹552.90 |
|---|---|
| Market capitalisation | ₹1,785 crore |
| Enterprise value | ₹1,875 crore |
| P/E (TTM) | 0.00 |
| Price to book | 2.02 |
| Price to sales (TTM) | 2.07 |
| Book value per share | ₹273.44 |
| Dividend yield | 49.74% |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Listed since | Mon Aug 16 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹734 crore | ₹132 crore | ₹103 crore | 0.00 |
| Mar 2025 | ₹707 crore | ₹110 crore | ₹83 crore | 25.65 |
| Mar 2024 | ₹607 crore | ₹72 crore | ₹59 crore | 18.45 |
| Mar 2023 | ₹483 crore | ₹82 crore | ₹64 crore | 20.23 |
| Mar 2022 | ₹470 crore | ₹90 crore | ₹71 crore | 23.66 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 27.1% |
|---|---|
| Foreign institutions (FII) | 4.3% |
| Mutual funds | 10.2% |
| Other domestic institutions | 4.3% |
| Retail and others | 54.1% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.